PRIMA-1 cytotoxicity correlates with nucleolar localization and degradation of mutant p53 in breast cancer cells

Debora Russo, Laura Ottaggio, Ilaria Penna, Giorgia Foggetti, Gilberto Fronza, Alberto Inga, Paola Menichini

Research output: Contribution to journalArticle

Abstract

PRIMA-1 has been identified as a compound that restores the transactivation function to mutant p53 and induces apoptosis in cells expressing mutant p53. Studies on subcellular distribution of the mutant p53 protein upon treatment with PRIMA-1Met, a methylated form of PRIMA-1, have suggested that redistribution of mutant p53 to nucleoli may play a role in PRIMA-1 induced apoptosis. Here, we specifically investigated the influence of PRIMA-1 on cellular localization of mutated p53-R280K endogenously expressed in tumour cells. By using immunofluorescence staining, we found a strong nucleolar redistribution of mutant p53 following PRIMA-1 treatment. This subcellular localization was associated to p53 degradation via ubiquitylation. When cells were treated with adriamycin, neither nucleolar redistribution nor mutant p53 down modulation and degradation were observed. Interestingly, cells where p53-R280K was silenced were more sensitive to PRIMA-1 than the parental ones. These results indicate that in some cellular context, the cell sensitivity to PRIMA-1 could depend on the abolition of a gain-of-function activity of the mutated p53, through a protein degradation pathway specifically induced by this compound.

Original languageEnglish
Pages (from-to)345-350
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume402
Issue number2
DOIs
Publication statusPublished - Nov 12 2010

Fingerprint

Cytotoxicity
Cells
Breast Neoplasms
Degradation
Apoptosis
Ubiquitination
Mutant Proteins
2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one
Doxorubicin
Transcriptional Activation
Proteolysis
Fluorescent Antibody Technique
Tumors
Proteins
Modulation
Staining and Labeling
Therapeutics
Neoplasms

Keywords

  • Breast cancer
  • Mutant p53
  • Nucleolus
  • P53 degradation
  • P53 ubiquitylation
  • PRIMA-1

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

PRIMA-1 cytotoxicity correlates with nucleolar localization and degradation of mutant p53 in breast cancer cells. / Russo, Debora; Ottaggio, Laura; Penna, Ilaria; Foggetti, Giorgia; Fronza, Gilberto; Inga, Alberto; Menichini, Paola.

In: Biochemical and Biophysical Research Communications, Vol. 402, No. 2, 12.11.2010, p. 345-350.

Research output: Contribution to journalArticle

@article{d08e64edcbc94be6b8c312dfd4749585,
title = "PRIMA-1 cytotoxicity correlates with nucleolar localization and degradation of mutant p53 in breast cancer cells",
abstract = "PRIMA-1 has been identified as a compound that restores the transactivation function to mutant p53 and induces apoptosis in cells expressing mutant p53. Studies on subcellular distribution of the mutant p53 protein upon treatment with PRIMA-1Met, a methylated form of PRIMA-1, have suggested that redistribution of mutant p53 to nucleoli may play a role in PRIMA-1 induced apoptosis. Here, we specifically investigated the influence of PRIMA-1 on cellular localization of mutated p53-R280K endogenously expressed in tumour cells. By using immunofluorescence staining, we found a strong nucleolar redistribution of mutant p53 following PRIMA-1 treatment. This subcellular localization was associated to p53 degradation via ubiquitylation. When cells were treated with adriamycin, neither nucleolar redistribution nor mutant p53 down modulation and degradation were observed. Interestingly, cells where p53-R280K was silenced were more sensitive to PRIMA-1 than the parental ones. These results indicate that in some cellular context, the cell sensitivity to PRIMA-1 could depend on the abolition of a gain-of-function activity of the mutated p53, through a protein degradation pathway specifically induced by this compound.",
keywords = "Breast cancer, Mutant p53, Nucleolus, P53 degradation, P53 ubiquitylation, PRIMA-1",
author = "Debora Russo and Laura Ottaggio and Ilaria Penna and Giorgia Foggetti and Gilberto Fronza and Alberto Inga and Paola Menichini",
year = "2010",
month = "11",
day = "12",
doi = "10.1016/j.bbrc.2010.10.031",
language = "English",
volume = "402",
pages = "345--350",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - PRIMA-1 cytotoxicity correlates with nucleolar localization and degradation of mutant p53 in breast cancer cells

AU - Russo, Debora

AU - Ottaggio, Laura

AU - Penna, Ilaria

AU - Foggetti, Giorgia

AU - Fronza, Gilberto

AU - Inga, Alberto

AU - Menichini, Paola

PY - 2010/11/12

Y1 - 2010/11/12

N2 - PRIMA-1 has been identified as a compound that restores the transactivation function to mutant p53 and induces apoptosis in cells expressing mutant p53. Studies on subcellular distribution of the mutant p53 protein upon treatment with PRIMA-1Met, a methylated form of PRIMA-1, have suggested that redistribution of mutant p53 to nucleoli may play a role in PRIMA-1 induced apoptosis. Here, we specifically investigated the influence of PRIMA-1 on cellular localization of mutated p53-R280K endogenously expressed in tumour cells. By using immunofluorescence staining, we found a strong nucleolar redistribution of mutant p53 following PRIMA-1 treatment. This subcellular localization was associated to p53 degradation via ubiquitylation. When cells were treated with adriamycin, neither nucleolar redistribution nor mutant p53 down modulation and degradation were observed. Interestingly, cells where p53-R280K was silenced were more sensitive to PRIMA-1 than the parental ones. These results indicate that in some cellular context, the cell sensitivity to PRIMA-1 could depend on the abolition of a gain-of-function activity of the mutated p53, through a protein degradation pathway specifically induced by this compound.

AB - PRIMA-1 has been identified as a compound that restores the transactivation function to mutant p53 and induces apoptosis in cells expressing mutant p53. Studies on subcellular distribution of the mutant p53 protein upon treatment with PRIMA-1Met, a methylated form of PRIMA-1, have suggested that redistribution of mutant p53 to nucleoli may play a role in PRIMA-1 induced apoptosis. Here, we specifically investigated the influence of PRIMA-1 on cellular localization of mutated p53-R280K endogenously expressed in tumour cells. By using immunofluorescence staining, we found a strong nucleolar redistribution of mutant p53 following PRIMA-1 treatment. This subcellular localization was associated to p53 degradation via ubiquitylation. When cells were treated with adriamycin, neither nucleolar redistribution nor mutant p53 down modulation and degradation were observed. Interestingly, cells where p53-R280K was silenced were more sensitive to PRIMA-1 than the parental ones. These results indicate that in some cellular context, the cell sensitivity to PRIMA-1 could depend on the abolition of a gain-of-function activity of the mutated p53, through a protein degradation pathway specifically induced by this compound.

KW - Breast cancer

KW - Mutant p53

KW - Nucleolus

KW - P53 degradation

KW - P53 ubiquitylation

KW - PRIMA-1

UR - http://www.scopus.com/inward/record.url?scp=78149431656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149431656&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.10.031

DO - 10.1016/j.bbrc.2010.10.031

M3 - Article

C2 - 20946886

AN - SCOPUS:78149431656

VL - 402

SP - 345

EP - 350

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -